ACAM2000

ACAM2000 is a smallpox vaccine that is used to protect against the variola virus, the causative agent of smallpox. It is a live, attenuated vaccine derived from the vaccinia virus, which is closely related to the variola virus. ACAM2000 is administered using a bifurcated needle, a method that is distinct from the typical intramuscular or subcutaneous injections used for many other vaccines.
History[edit]
The development of ACAM2000 was initiated in response to the need for a safer and more effective smallpox vaccine. The original smallpox vaccine, known as Dryvax, was used during the global smallpox eradication campaign led by the World Health Organization (WHO). However, Dryvax was associated with certain adverse effects, prompting the development of ACAM2000 as a second-generation vaccine.
Administration[edit]
ACAM2000 is administered using a bifurcated needle, which is dipped into the vaccine solution and then used to prick the skin multiple times in a small area, usually on the upper arm. This method creates a localized infection with the vaccinia virus, leading to the development of immunity against smallpox. The site of vaccination typically develops a pustule, which eventually scabs over and heals, leaving a small scar.
Efficacy and Safety[edit]
ACAM2000 has been shown to be effective in inducing immunity against smallpox. However, as with any live vaccine, there are potential risks and side effects. Common side effects include mild fever, fatigue, and localized skin reactions. More serious complications, such as myocarditis and pericarditis, have been reported, although they are rare.
Use in Biodefense[edit]
Due to the potential use of smallpox as a bioterrorism agent, ACAM2000 is stockpiled by various governments as part of their biodefense strategies. The vaccine is not used in routine immunization programs, as smallpox was declared eradicated in 1980. However, it remains an important tool for emergency preparedness.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian